CA Dinarello is a scholar working on Immunology, Oncology and Molecular Biology.
According to data from OpenAlex, CA Dinarello has authored 72 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Immunology, 14 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in CA Dinarello's work include Immune Response and Inflammation (31 papers), Immune Cell Function and Interaction (12 papers) and Cytokine Signaling Pathways and Interactions (12 papers). CA Dinarello is often cited by papers focused on Immune Response and Inflammation (31 papers), Immune Cell Function and Interaction (12 papers) and Cytokine Signaling Pathways and Interactions (12 papers). CA Dinarello collaborates with scholars based in United States, Netherlands and Italy. CA Dinarello's co-authors include Herbert Tilg, Stefan Endres, Javier Mancilla-Ramı́rez, R Ghorbani, SC Clark, R. N. Schindler, Elizabeth Trehu, MB Atkins, J W Mier and Ralf Schindler and has published in prestigious journals such as Blood, Journal of Lipid Research and Annals of the Rheumatic Diseases.
In The Last Decade
CA Dinarello
72 papers
receiving
9.4k citations
Hit Papers
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Correlations and interactions in the production of interleukin-6 (IL- 6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF
1990840 citationsCA Dinarello et al.Bloodprofile →
Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55
1994668 citationsCA Dinarello et al.Bloodprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of CA Dinarello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CA Dinarello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CA Dinarello more than expected).
This network shows the impact of papers produced by CA Dinarello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CA Dinarello. The network helps show where CA Dinarello may publish in the future.
Co-authorship network of co-authors of CA Dinarello
This figure shows the co-authorship network connecting the top 25 collaborators of CA Dinarello.
A scholar is included among the top collaborators of CA Dinarello based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with CA Dinarello. CA Dinarello is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Dinarello, CA. (1997). Induction of interleukin-1 and interleukin-1 receptor antagonist.. PubMed. 24(3 Suppl 9). S9–81.46 indexed citations
3.
Dinarello, CA. (1996). Controlling the production of interleukin-1 and tumor necrosis factor in disease.. PubMed. 11(5 Suppl). 695–7.8 indexed citations
4.
Dinarello, CA. (1995). To Sheldon M. Wolff, as we commemorate the 10th anniversary of the clonings of IL-1 alpha and IL-1 beta.. PubMed. 5(6). 513–6.2 indexed citations
Dinarello, CA. (1992). Reduction of inflammation by decreasing production of interleukin-1 or by specific receptor antagonism.. PubMed. 14(2). 65–75.36 indexed citations
7.
Dinarello, CA. (1992). Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis.. PubMed. 38. S68–77.42 indexed citations
Endres, Stephan, et al.. (1991). Effect of oral n-3 fatty acid supplementation on the immune response of young and older women.. PubMed. 21A. 245–8.10 indexed citations
11.
Dinarello, CA. (1991). Interleukin-1 and interleukin-1 antagonism. Blood. 77(8). 1627–1652.1964 indexed citations breakdown →
Schindler, Ralf, Pietro Ghezzi, & CA Dinarello. (1989). Interferons as inhibitors of interleukin 1 induced interleukin 1 synthesis.. PubMed. 8(3). 275–80.13 indexed citations
14.
Shaldon, Stanley & CA Dinarello. (1988). The relationship between biocompatibility and interleukin-1.. PubMed. 5(4). 341–5.10 indexed citations
15.
Dinarello, CA, Koch Km, & Stanley Shaldon. (1988). Interleukin-1 and its relevance in patients treated with hemodialysis.. PubMed. 24. S21–6.54 indexed citations
Dinarello, CA, et al.. (1987). The stimulation of collagenase production in rabbit articular chondrocytes by interleukin-1 is increased by collagens.. PubMed. 15(5). 1021–31.9 indexed citations
18.
Dinarello, CA, et al.. (1985). Effect of protein synthesis inhibitors on leukocytic pyrogen-induced in vitro hypothalamic prostaglandin production.. PubMed. 58(2). 179–87.11 indexed citations
19.
Dinarello, CA, et al.. (1985). Chemical characterization of an interleukin-1-inducing substance derived from human mixed leukocyte reactions: IL-1-inducing substance is not gamma interferon.. PubMed. 58(2). 101–13.11 indexed citations
20.
Dinarello, CA. (1979). Production of endogenous pyrogen.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(1). 52–6.41 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.